![Milken Institute holds London Summit](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Milken Institute holds London Summit
![In the latest Milken Institute Review: Brad DeLong, a Former Clinton Administration Economist, Challenges the Conventional Wisdom That the Rich Market Economies Can Thrive Without Aggressive Government Intervention](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
In the latest Milken Institute Review: Brad DeLong, a Former Clinton Administration Economist, Challenges the Conventional Wisdom That the Rich Market Economies Can Thrive Without Aggressive Government Intervention
![Milken Institute Expands in London with Appointment of James Morgon](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Milken Institute Expands in London with Appointment of James Morgon
![Medical Research Visionaries Convene in New York, Present Model Solutions to Life Sciences’ Most Pressing Challenges](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Medical Research Visionaries Convene in New York, Present Model Solutions to Life Sciences’ Most Pressing Challenges
![Vice President Biden Names Founding President of FasterCures to Lead Cancer Moonshot](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Vice President Biden Names Founding President of FasterCures to Lead Cancer Moonshot
![Dementia Exacts Heaviest Toll on Women: New Milken Institute Report Quantifies the Direct and Indirect Economic Effects of Cognitive Loss](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Dementia Exacts Heaviest Toll on Women: New Milken Institute Report Quantifies the Direct and Indirect Economic Effects of Cognitive Loss
![Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions](/sites/default/files/oembed_thumbnails/JlLfWoG6g3_Hn-6oojseDzZVHbuvbXGR9leDf91hzyA.jpg)
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions
![Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?](/sites/default/files/oembed_thumbnails/dEo6YmV-dTUReJPHodu4AMXDxQzl2fD2HixmowKYrz0.jpg)
Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?
![Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health](/sites/default/files/oembed_thumbnails/WV-DfpXQJDoQ-F6iVx6zpjHjo5TZs5uUd8yDTgq3tA4.jpg)
Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health
![Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock](/sites/default/files/oembed_thumbnails/rKmDUGuyj6bDsY0q4dbwSaOpSHKtESrqw8EfmPEsyeU.jpg)
Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock
![Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation](/sites/default/files/oembed_thumbnails/SvlFtGvB5bPq9wCMqPh7UFBmt2_vuvdvT0H78THFTeQ.jpg)
Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation
![Dec. 7 at 2:30 pm ET | The Road Ahead for Improving Access to Testing and Treatment for Rare Diseases](/sites/default/files/oembed_thumbnails/HdJdQqLDLzG8SvEWzamcEsV_e2WBHifpXiRu1SPGcoo.jpg)